Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China SFDA Vows To Find, Prosecute ‘Made In India’ Chinese Drug Makers

This article was originally published in PharmAsia News

Executive Summary

China's State FDA says it will investigate allegations that some drugs are being made in China for sale abroad and labeled "Made in India." The action stemmed from anti-malaria drugs seized by Nigeria's Drug Regulatory Authority, enough to treat 642,000 adults. An SFDA spokesperson said the agency is sending investigators to Chinese provinces where the drugs allegedly were made. Another official said the guilty companies would be prosecuted, but advised pharmacy companies in other countries to deal only with Chinese firms recognized by SFDA. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel